Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Leading Yerba Maté Brand Gets Boost by Partnering with Oasis Sales and Marketing
Company announces a strategic partnership with Oasis Sales & Marketing to expand sales programs.
- Spectrum Organic Products Reports Sales for 2004
Company reports net sales for FY04 of $49,915,400 versus $45,676,500 prior year, with the Spectrum Naturals(R) brand of culinary products up 17% and the Spectrum Ingredients Division industrial culinary sales increasing by 11%. Company's Spectrum Essentials(R) brand of nutritional supplements had sales fall by 8%. Company reports net loss of $832,700 or $0.02 per share versus net income of $2,663,600 ($0.06 per share) for the prior year.
- Spectrum Organic Products Reports Sales for 2004
Company reports net sales for FY04 of $49,915,400 versus $45,676,500 prior year, with the Spectrum Naturals(R) brand of culinary products up 17% and the Spectrum Ingredients Division industrial culinary sales increasing by 11%. Company's Spectrum Essentials(R) brand of nutritional supplements had sales fall by 8%. Company reports net loss of $832,700 or $0.02 per share versus net income of $2,663,600 ($0.06 per share) for the prior year.
- BioGaia Signs Agreement In India
Company sings agreement with India's Uni-Sankyo that gives Uni-Sankyo the right to produce and sell dietary supplements with Reuteri in India.
- BioGaia Signs Agreement In India
Company sings agreement with India's Uni-Sankyo that gives Uni-Sankyo the right to produce and sell dietary supplements with Reuteri in India.
- Ariel Calmanovici Named CFO of Frutarom USA Inc.
Company appoints Ariel Calmanovici as Chief Financial Officer of Frutarom USA INc.
- Ariel Calmanovici Named CFO of Frutarom USA Inc.
Company appoints Ariel Calmanovici as Chief Financial Officer of Frutarom USA INc.
- Ariel Calmanovici Named CFO of Frutarom USA Inc.
Company appoints Ariel Calmanovici as Chief Financial Officer of Frutarom USA INc.
- Ariel Calmanovici Named CFO of Frutarom USA Inc.
Company appoints Ariel Calmanovici as Chief Financial Officer of Frutarom USA INc.
- SunOpta Announces 2004 Year End Results
Company reports sales of $306,251,000 compared to $199,099,000 in 2003 led by a 57% increase in revenues within the Company's vertically integrated food operations, focused on the natural and organic foods markets.
- SunOpta Announces 2004 Year End Results
Company reports sales of $306,251,000 compared to $199,099,000 in 2003 led by a 57% increase in revenues within the Company's vertically integrated food operations, focused on the natural and organic foods markets.
- Praesidian Capital Supports the Acquisition of Nutritional Laboratories
Company provided $7.2 million in Subordinated Debt to support the acquisition of Nutritional Laboratories International, Inc. by management and Red Diamond Capital, L.P.
- Praesidian Capital Supports the Acquisition of Nutritional Laboratories
Company provided $7.2 million in Subordinated Debt to support the acquisition of Nutritional Laboratories International, Inc. by management and Red Diamond Capital, L.P.
- Martek Announces First Quarter Financial Results
Company reports revenues of $66.5 million compared to $35.6 million Q1 prior year, with net income of $7.1 million, or $0.23 per diluted share, compared to $3.4 million, or $0.11 per diluted share previus year.
- Martek Announces First Quarter Financial Results
Company reports revenues of $66.5 million compared to $35.6 million Q1 prior year, with net income of $7.1 million, or $0.23 per diluted share, compared to $3.4 million, or $0.11 per diluted share previus year.
- Zila Announces Results for Its Fiscal 2005 Second Quarter
Company reports net revenues of $13.3 million, down from $13.6 million prior year, Zila Nutraceuticals revenues increased by $1.2 million to $9.8 million. Overall, company reports a net loss for the quarter of $2.7 million, or six cents per share, compared to a loss of $1.0 million, or two cents per share prior year.
- Zila Announces Results for Its Fiscal 2005 Second Quarter
Company reports net revenues of $13.3 million, down from $13.6 million prior year, Zila Nutraceuticals revenues increased by $1.2 million to $9.8 million. Overall, company reports a net loss for the quarter of $2.7 million, or six cents per share, compared to a loss of $1.0 million, or two cents per share prior year.
- KGK Synergize and Lecigel Enter Into a Joint Venture Agreement For Sytrinol(TM)
Companies confirm Joint Venture (JV) agreement involving a Sytrinol combination and LeciGel’s technology, with intent to commercialize the resulting technology into the functional food and beverage market.
- KGK Synergize and Lecigel Enter Into a Joint Venture Agreement For Sytrinol(TM)
Companies confirm Joint Venture (JV) agreement involving a Sytrinol combination and LeciGel’s technology, with intent to commercialize the resulting technology into the functional food and beverage market.
- KGK Synergize and Lecigel Enter Into a Joint Venture Agreement For Sytrinol(TM)
Companies confirm Joint Venture (JV) agreement involving a Sytrinol combination and LeciGel’s technology, with intent to commercialize the resulting technology into the functional food and beverage market.
- KGK Synergize and Lecigel Enter Into a Joint Venture Agreement For Sytrinol(TM)
Companies confirm Joint Venture (JV) agreement involving a Sytrinol combination and LeciGel’s technology, with intent to commercialize the resulting technology into the functional food and beverage market.
- KGK Synergize and Lecigel Enter Into a Joint Venture Agreement For Sytrinol(TM)
Companies confirm Joint Venture (JV) agreement involving a Sytrinol combination and LeciGel’s technology, with intent to commercialize the resulting technology into the functional food and beverage market.
- KGK Synergize and Lecigel Enter Into a Joint Venture Agreement For Sytrinol(TM)
Companies confirm Joint Venture (JV) agreement involving a Sytrinol combination and LeciGel’s technology, with intent to commercialize the resulting technology into the functional food and beverage market.
- KGK Synergize and Lecigel Enter Into a Joint Venture Agreement For Sytrinol(TM)
Companies confirm Joint Venture (JV) agreement involving a Sytrinol combination and LeciGel’s technology, with intent to commercialize the resulting technology into the functional food and beverage market.
- P.L. Thomas and Laila Impex Announce Strategic Alliance
Alliance formally recognizes commitment to an intensified and united approach to advanced ingredient discoveries.
- P.L. Thomas and Laila Impex Announce Strategic Alliance
Alliance formally recognizes commitment to an intensified and united approach to advanced ingredient discoveries.
- Herbalife International Appoints Melanie Hayden General Manager of Herbalife Canada
Company appoints Melanie Hayden as general manager of Herbalife Canada, reporting to Rob Levy, senior vice president of the company's Americas region.
- Herbalife International Appoints Melanie Hayden General Manager of Herbalife Canada
Company appoints Melanie Hayden as general manager of Herbalife Canada, reporting to Rob Levy, senior vice president of the company's Americas region.
- Herbalife International Appoints Melanie Hayden General Manager of Herbalife Canada
Company appoints Melanie Hayden as general manager of Herbalife Canada, reporting to Rob Levy, senior vice president of the company's Americas region.
- Herbalife International Appoints Melanie Hayden General Manager of Herbalife Canada
Company appoints Melanie Hayden as general manager of Herbalife Canada, reporting to Rob Levy, senior vice president of the company's Americas region.
- Symrise Acquires English Flavor Manufacturer Flavours Direct
Company will acquire the British flavor manufacturer Flavours Direct as of 31st of March 2005; deal intended to strengthen its position in Great Britain and Ireland, and to make the company one of the foremost suppliers of savory flavors in Great Britain.
- Symrise Acquires English Flavor Manufacturer Flavours Direct
Company will acquire the British flavor manufacturer Flavours Direct as of 31st of March 2005; deal intended to strengthen its position in Great Britain and Ireland, and to make the company one of the foremost suppliers of savory flavors in Great Britain.
- OptiPure® Brand Chemco Industries, Inc. and Use Techno Sign an Exclusive Distribution and Marketing Agreement
Companies sign agreement on GlucoTrim® Banaba leaf extract where OptiPure® and Soft Gel Technologies Inc.®, (SGTI®) are now the exclusive source for Banaba leaf extracts typically used in soft gelatin capsules, tablets, and two piece hard shell capsules.
- OptiPure® Brand Chemco Industries, Inc. and Use Techno Sign an Exclusive Distribution and Marketing Agreement
Companies sign agreement on GlucoTrim® Banaba leaf extract where OptiPure® and Soft Gel Technologies Inc.®, (SGTI®) are now the exclusive source for Banaba leaf extracts typically used in soft gelatin capsules, tablets, and two piece hard shell capsules.
- OptiPure® Brand Chemco Industries, Inc. and Use Techno Sign an Exclusive Distribution and Marketing Agreement
Companies sign agreement on GlucoTrim® Banaba leaf extract where OptiPure® and Soft Gel Technologies Inc.®, (SGTI®) are now the exclusive source for Banaba leaf extracts typically used in soft gelatin capsules, tablets, and two piece hard shell capsules.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- AMS Health Sciences Announces 2004 Year-End Financial Results
Company reports net sales of $18.5 million for FY04 compared to $18.5 million prior year; 2004 net loss reported at $6.3 million, or $(0.90) per common and diluted share, compared to a net loss of $2.6 million, or $(0.57) per common and diluted share in 2003.
- AMS Health Sciences Announces 2004 Year-End Financial Results
Company reports net sales of $18.5 million for FY04 compared to $18.5 million prior year; 2004 net loss reported at $6.3 million, or $(0.90) per common and diluted share, compared to a net loss of $2.6 million, or $(0.57) per common and diluted share in 2003.
- E.T. Horn Company Selected By Loders Croklaan as Exclusive Distributor of SensoryEffects(TM) Products in Western States
Company signs distribution agreement with Loders Croklaan to represent its line of SensoryEffects(TM) inclusions throughout the western United States.
- E.T. Horn Company Selected By Loders Croklaan as Exclusive Distributor of SensoryEffects(TM) Products in Western States
Company signs distribution agreement with Loders Croklaan to represent its line of SensoryEffects(TM) inclusions throughout the western United States.
- Natrol Announces 2004 Results
Company reports net income of $1.9 million or $0.13 per diluted share compared to a net loss of $1.5 million or $0.11 per share prior year; net sales for 2004 rose 9.1%, from $72.7 million to $79.3 million.
- Natrol Announces 2004 Results
Company reports net income of $1.9 million or $0.13 per diluted share compared to a net loss of $1.5 million or $0.11 per share prior year; net sales for 2004 rose 9.1%, from $72.7 million to $79.3 million.
- Enzymotec Targets South-East Asia Functional Oils Market
Company declares intention of penetrating functional oils market of South-East Asia and Western Pacific.
- Enzymotec Targets South-East Asia Functional Oils Market
Company declares intention of penetrating functional oils market of South-East Asia and Western Pacific.
- EuroPharma and Enzymatic Therapy Sign Licensing and Distribution Agreement
Enzymatic Therapy to take over marketing, sales and dsitribution of Europharma's SneezEze and Renouvelle products.
- EuroPharma and Enzymatic Therapy Sign Licensing and Distribution Agreement
Enzymatic Therapy to take over marketing, sales and dsitribution of Europharma's SneezEze and Renouvelle products.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- SourceOne(TM) Announces Joint Venture Agreement with American River Nutrition
Company to provide marketng and sales to scientific support, product development and manufacturing contribution of American River Nutrition.
- SourceOne(TM) Announces Joint Venture Agreement with American River Nutrition
Company to provide marketng and sales to scientific support, product development and manufacturing contribution of American River Nutrition.
- Nutritional Laboratories International Signs Equity Deal with Red Diamond Capital
Company finalizes a deal with private equity firm Red Diamond Capital.
- Nutritional Laboratories International Signs Equity Deal with Red Diamond Capital
Company finalizes a deal with private equity firm Red Diamond Capital.
- Glykon Technologies Group Ends HCA Licensing Agreement with Renaissance Herbs
Company has terminated its licensing agreement with Renaissance Herbs, Inc. covering uses and delivery systems for (–)-hydroxycitric acid and related products, effective February 4, 2005.
- Glykon Technologies Group Ends HCA Licensing Agreement with Renaissance Herbs
Company has terminated its licensing agreement with Renaissance Herbs, Inc. covering uses and delivery systems for (–)-hydroxycitric acid and related products, effective February 4, 2005.
- ACNielsen and SPINS Expand Coverage of Fast-Growing Natural Products Industry
Companies announce expansion of SPINSscan Conventional information service tracking sales of natural and organic products across grocery, drug, and mass merchandise retail outlets; For the first time, retailer-specific analysis of natural and organic product sales will be available from the service, and the number of categories tracked will nearly double.
- ACNielsen and SPINS Expand Coverage of Fast-Growing Natural Products Industry
Companies announce expansion of SPINSscan Conventional information service tracking sales of natural and organic products across grocery, drug, and mass merchandise retail outlets; For the first time, retailer-specific analysis of natural and organic product sales will be available from the service, and the number of categories tracked will nearly double.
- Tate & Lyle Interim Results Announcement 2009
Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year.
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Taming Fear of the H1N1 Flu Vaccine
- Taming Fear of the H1N1 Flu Vaccine
- Natural Cold and Flu Remedies: Do They Help?
- Natural Cold and Flu Remedies: Do They Help?
- Exercise as Pain Therapy
- Exercise as Pain Therapy
|
CORONA, Calif., Mar 14, 2005 (BUSINESS WIRE) -- Hansen Natural Corporation (HANS) today announced record sales and profits for the year and fourth quarter ended December 31, 2004.
For the 2004 year, gross sales rose 63.9 percent to $227.0 million from $138.5 million in 2003. Net sales for 2004 increased 63.4 percent to $180.3 million from $110.4 million in the prior year. Operating income grew 244.9 percent in 2004 to $33.9 million from $9.8 million a year ago. Net income advanced 243.8 percent to $20.4 million, or $1.73 per diluted share, from $5.9 million, or $0.55 per diluted share, a year ago.
Rodney C. Sacks, chairman and chief executive officer, said the record sales and profits for 2004 were primarily attributable to substantially increased sales volumes of the company's Monster Energy(R) drinks and Lo-Carb Monster Energy(R) drinks, and to a lesser extent, to sales volumes of Lost(R) energy drinks which were introduced at the beginning of 2004. Increased sales volumes of apple juice and apple grape juice, private label beverages and Energade(R) energy sports drinks also contributed to the record sales. He added that the increase in sales was partially offset by decreased sales volumes primarily of Hansen's energy drinks in 8.3-ounce cans, children's multi-vitamin juice drinks, and teas, lemonades and cocktails.
Gross profit as a percentage of net sales for the year rose to 46.3 percent from 39.7 percent in 2003, primarily due to increased sales of higher margin Monster Energy(TM) and Lost(R) energy drinks. Selling, general and administrative expenses as a percentage of net sales were slightly lower than in the previous year.
For the 2004 fourth quarter, gross sales rose 87.8 percent to $62.1 million from $33.1 million a year earlier. Net sales increased 89.5 percent to $50.3 million from $26.6 million in 2003. Operating income increased to $11.9 million from $1.9 million a year ago. Net income increased to $7.3 million, or $0.61 per diluted share, from $1.2 million, or $0.11 per diluted share, in the comparable period in 2003.
The increase in net income for the fourth quarter compared with the prior year period was primarily attributable to the substantial increase in sales volumes of Monster Energy(TM) drinks.
Sacks also said the company is currently launching a new 100% energy juice in 15.5-ounce cans under the Rumba(TM) brand name. Sales of Monster Energy(TM) "Assault" energy drinks and Monster Energy(TM) drinks in 4-packs, both of which were launched recently, were in line with expectations. He said management was pleased with the ongoing implementation of the WIC contracts.
Hansen Natural Corporation markets and distributes Hansen's(R) Natural Sodas, Signature Sodas, fruit juice and soy Smoothies, Energy drinks, Energade(R) energy sports drinks, E20 Energy Water(R), functional drinks, Sparkling Lemonades and Orangeades, multi-vitamin juice drinks in aseptic packaging, Junior Juice(R) juice, iced teas, lemonades and juice cocktails, apple juice, cider and juice blends, as well as nutrition bars, Blue Sky(R) brand carbonated beverages, Monster Energy(TM) brand energy drinks, Lost(R) Energy(TM) brand energy drinks and Rumba(TM) brand energy drinks. Hansen's can be found on the Web at www.hansens.com.
Certain statements made in this announcement may constitute "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding the expectations of management with respect to revenues and profitability. Management cautions that these statements are qualified by their terms/or important factors, many of which are outside of the control of the company, that could cause actual results and events to differ materially from the statements made herein, including, but not limited to, the following: Changes in consumer preferences, changes in demand that are weather related, particularly in areas outside of California, competitive pricing pressures, changes in the price and/or availability of raw materials for the company's products, the availability of production and/or suitable facilities, the marketing efforts of the distributors of the company's products, most of which distribute products that are competitive with the products of the company, the introduction of new products, as well as unilateral decisions that may be made by grocery chain stores, specialty chain stores, club stores and other customers to discontinue carrying all or any of the company's products that they are carrying at any time. Management further notes that the company's plans and results may be affected by any change in the availability of the company's credit facilities and the actions of its creditors. |